Blood test sheds light on hidden clotting disorder
NCT ID NCT06373926
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at a protein called annexin A2 on the surface of certain white blood cells (monocytes) in people with antiphospholipid syndrome, a condition that raises the risk of blood clots and pregnancy complications. Researchers will compare the amount of this protein between patients and healthy volunteers to see if lower levels are linked to the disease. No treatments or drugs are tested โ the goal is simply to learn more about what causes the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
RECRUITINGAmiens, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood platelet trends may reveal hidden risk in autoimmune disease
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test tell two forms of a clotting disorder apart?
- New fingerstick test for blood thinner monitoring put to the test
- New MRI study seeks hidden stroke causes in rare blood disorder
- New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin